Actively Recruiting
Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Other Perceptual Indicators
Led by Lindenwood University · Updated on 2025-12-12
60
Participants Needed
1
Research Sites
37 weeks
Total Duration
On this page
Sponsors
L
Lindenwood University
Lead Sponsor
I
Increnovo LLC
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the dose-dependent effects of glucosyl-hesperidin (CITRAPEAK) supplementation on exercise performance, recovery indicators, blood flow, cognitive function, mood, sleep, and fuel utilization in recreationally active adults.
CONDITIONS
Official Title
Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Other Perceptual Indicators
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants aged between 18 and 50 years
- Body mass index between greater than 25.0 and less than 30.0 kg/m2
- Average study cohort body mass index less than 27.0 kg/m2
- Free-living and independent
- In good health without cardiovascular, respiratory, metabolic, immune, psychiatric, or musculoskeletal diseases
- Willing to maintain consistent sleep duration before study visits
- Willing and able to consent and follow all study procedures
- Regularly complete at least 180 minutes of moderate to vigorous exercise weekly for the past 6 months
You will not qualify if you...
- Not completing at least 180 minutes of moderate to vigorous exercise weekly for the past 6 months
- History or treatment of heart or cardiovascular disease
- Current kidney disease, renal failure, or dialysis
- Liver disease or clinically diagnosed hepatic impairment
- Diagnosed with Type I or Type II diabetes
- Thyroid disease diagnosis or treatment
- Major psychiatric disorder requiring hospitalization in the past year
- Immune disorders such as HIV/AIDS
- History of cancer except localized skin or in situ cervical cancer within 5 years
- Gastrointestinal tract abnormalities preventing swallowing or digestion
- Neurological conditions or diseases
- Currently prescribed statin or hypertension medications
- Current smoker or quit within past six months
- Use of weight loss drugs or supplements like thermogenics or ephedra
- Lactating, pregnant, or planning pregnancy
- Known allergy to study products
- History of alcohol or substance abuse in past 12 months
- Use of investigational products within 30 days before study
- Orthopedic limitations preventing fitness program participation
- Any condition compromising safety or study data quality per investigator judgment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Lindenwood University
Saint Charles, Missouri, United States, 63301
Actively Recruiting
Research Team
A
Anthony M Hagele, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here